Outcomes after Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer

被引:3
|
作者
Pantelis, Dimitrios [1 ]
Lingohr, Philipp [1 ]
Hueneburg, Robert [2 ]
Spier, Isabel [3 ]
Vilz, Tim [1 ]
Lau, Jan F. [4 ]
Nattermann, Jacob [2 ]
Aretz, Stefan [2 ]
Strassburg, Christian P. [2 ]
Kalff, Joerg C. [1 ]
机构
[1] Univ Klinikum Bonn, Klin & Poliklin Allgemein Viszeral Thorax & Gefas, Bonn, Germany
[2] Univ Klinikum Bonn, Medizin Klin & Poliklin 1, Allgemeine Innere Med, Bonn, Germany
[3] Univ Klinikum Bonn, Inst Humangenet, Bonn, Germany
[4] Univ Klinikum Bonn, Inst Pathol, Bonn, Germany
来源
ZENTRALBLATT FUR CHIRURGIE | 2020年 / 145卷 / 01期
关键词
hereditary diffuse gastric cancer; CDH1 germline mutation; prophylactic total gastrectomy; laparoscopic surgery; E-CADHERIN GENE; CLASSIFICATION; COMPLICATIONS; GUIDELINES; MANAGEMENT; MUTATIONS; COHORT; FOCI;
D O I
10.1055/a-0646-4382
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction Prophylactic total gastrectomy is the treatment of choice in patients with germline mutation in the CDH1 gene and therefore high risk for hereditary diffuse gastric cancer (HDGC). Minimally invasive techniques have been established in recent years for treatment of gastric cancer. Methods We report findings with 12 patients with proven CDH1 mutation who underwent multidisciplinary treatment between 2013 and 3/2018 in our centre for hereditary tu-mour diseases, followed by prophylactic total gastrectomy in our department. Data were collected in a prospective hereditary tumour database. Results Open prophylactic total gastrectomy was performed in 5 patients (between 2013 and 2015) andminimally invasive prospective gastrectomy in 7 patients (between 2015 and 2018). The median age of all patients (7 women and 5 men) was 42 (range: 19-60) years. The mean operation time was 291 +/- 72 minutes (open: 269 +/- 70; minimally invasive: 307 +/- 75). Perioperative 60-day mortality and anastomotic leakage rate were 0%. In 3 patients, postoperative complications occurred (according to the Clavien-Dindo classification: one each of grades II, IIIa and IVb, respectively), and therefore 25% morbidity. The average postoperative hospital stay was 14.5 +/- 6.2 days (open: 16.2 +/- 7.9; minimally invasive: 13.3 +/- 5.0). In 10 of 12 patients (83%), foci of intramucosal signet ring cell carcinomas were found in the gastric specimen, in 9 patients with multifocal dissemination. There were no cases with advanced carcinomas (>= pT1b) or lymph node metastases. Conclusion Patients with suspected high risk for hereditary diffuse gastric cancer should be cared for in a multidisciplinary centre for hereditary tumour diseases. Laparoscopic total gastrectomy is a safe and feasible risk-reducing procedure for patients with CDH1 germline mutation. Therefore, in the absence of contraindications and with available surgical expertise, the minimally invasive operation should be the standard procedure for these patients.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 50 条
  • [31] CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer: An Analysis of a Large Cohort Undergoing and Delaying Total Prophylactic Gastrectomy
    Benesch, Matthew G. K.
    Mathieson, Alexander
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 539 - 539
  • [32] Hereditary diffuse gastric cancer: Natural history, pathology, screening limitations, and prophylactic total gastrectomy in CDH1 mutation carriers
    Lynch, H. T.
    Caldas, C.
    Wirtzfeld, D.
    Vaccaro, C.
    Rubinstein, W.
    Weissman, S.
    Kaurah, P.
    Boyd, N.
    Fitzgerald, R.
    Huntsman, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer
    Seevaratnam, Rajini
    Coburn, Natalie
    Cardoso, Roberta
    Dixon, Matthew
    Bocicariu, Alina
    Helyer, Lucy
    GASTRIC CANCER, 2012, 15 : S153 - S163
  • [34] Chrontoendoscopic surveillance in a Maori kindred genotypically predisposed to hereditary diffuse gastric cancer: An alternative to prophylactic gastrectomy?
    Shaw, D
    Blair, V
    Martin, I
    GASTROINTESTINAL ENDOSCOPY, 2003, 57 (05) : AB158 - AB158
  • [35] Outcomes After Completion Total Gastrectomy for Gastric Remnant Cancer
    St-Louis, Etienne
    Gowing, Stephen D.
    Leimanis, Mara L.
    Mossallanejad, Pedram
    Mueller, Carmen L.
    Ferri, Lorenzo E.
    GASTROENTEROLOGY, 2015, 148 (04) : S1168 - S1168
  • [36] A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer
    Rajini Seevaratnam
    Natalie Coburn
    Roberta Cardoso
    Matthew Dixon
    Alina Bocicariu
    Lucy Helyer
    Gastric Cancer, 2012, 15 : 153 - 163
  • [37] Prophylactic total gastrectomy for familial gastric cancer - Discussion
    Stellato, TA
    Fischer, JE
    Michelassi, F
    Pickleman, J
    Dent, T
    Wislon, SD
    Madura, JA
    Mulder, DS
    SURGERY, 2001, 130 (04) : 617 - 619
  • [38] PROPHYLACTIC TOTAL GASTRECTOMY FOR HEREDITORY GASTRIC CANCER SYNDROME
    Rashid, F.
    Suo, C.
    Tan, B.
    Richardson, S.
    Fitzgerald, R.
    Di Pietro, M.
    Tischkowitz, M.
    O'Donovan, M.
    Hardwick, R. H.
    GUT, 2015, 64 : A126 - A126
  • [39] Hereditary diffuse gastric cancer: lifesaving total gastrectomy for CDH1 mutation carriers
    Lynch, Henry T.
    Lynch, Jane F.
    JOURNAL OF MEDICAL GENETICS, 2010, 47 (07) : 433 - 435
  • [40] A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer
    Chen, Yijun
    Kingham, Kerry
    Ford, James M.
    Rosing, James
    Van Dam, Jacques
    Jeffrey, R. Brooke
    Longacre, Teri A.
    Chun, Nicki
    Kurian, Allison
    Norton, Jeffrey A.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (09) : 2594 - 2598